Ye Guo, Liqiong Xue, Bihui Li, Jinguan Lin, Kunyu Yang, Meiyu Fang, Xuelei Ma, Sa Xiao, Hai Zhu, Yi Zhu. "Phase II study of izalontamab (SI-B001) in combination with paclitaxel or docetaxel in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6019